AFASEVIKUMAB
UNII TG8A3DSU6Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Afasevikumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TG8A3DSU6Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1589503-30-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TG8A3DSU6Z

CAS Registry Number

1589503-30-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AFASEVIKUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C169767

National Cancer Institute reference terminology for clinical and research data.

INN ID

10178

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-84

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Afasevikumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AFASEVIKUMAB

Common Names & Synonyms

AFASEVIKUMAB [INN]

AFASEVIKUMAB [USAN]

AFASEVIKUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 17 IL-17A/IL-17F) (HUMAN MONOCLONAL MCAF5352A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MCAF5352A LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A) AND HOMO SAPIENS IL17F (INTERLEUKIN 17F, IL-17F)), HOMO SAPIENS MONOCLONAL ANTIBODY